By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Biosergen AB (BIOSGN.ST)

STO Currency in SEK
kr 0.45
-kr 0.01
-3.04%
Last Update: 29 Aug 2025, 15:29
kr 104.97M
Market Cap
-3.95
P/E Ratio (TTM)
Forward Dividend Yield
kr 0.28 - kr 1.14
52 Week Range

BIOSGN.ST Stock Price Chart

Explore Biosergen AB interactive price chart. Choose custom timeframes to analyze BIOSGN.ST price movements and trends.

BIOSGN.ST Company Profile

Discover essential business fundamentals and corporate details for Biosergen AB (BIOSGN.ST) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

24 Jun 2021

Employees

2.00

CEO

Tine Kold Olesen

Description

Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.

BIOSGN.ST Financial Timeline

Browse a chronological timeline of Biosergen AB corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 21 May 2025

EPS came in at -kr 0.02 matching the estimated -kr 0.02.

Earnings released on 5 Mar 2025

EPS came in at -kr 0.02 matching the estimated -kr 0.02.

Earnings released on 8 Nov 2024

EPS came in at -kr 0.03 .

Earnings released on 30 Aug 2024

EPS came in at -kr 0.04 .

Earnings released on 31 May 2024

EPS came in at -kr 0.14 falling short of the estimated -kr 0.10 by -35.99%.

Earnings released on 29 Feb 2024

EPS came in at -kr 0.09 surpassing the estimated -kr 0.10 by +14.32%.

Earnings released on 30 Nov 2023

EPS came in at -kr 0.15 .

Earnings released on 14 Aug 2023

EPS came in at -kr 0.19 surpassing the estimated -kr 0.28 by +32.14%.

Earnings released on 31 May 2023

EPS came in at -kr 0.18 surpassing the estimated -kr 0.51 by +64.71%.

Earnings released on 31 Mar 2023

EPS came in at -kr 0.40 falling short of the estimated -kr 0.37 by -8.11%.

Earnings released on 30 Sept 2022

EPS came in at -kr 0.30 .

Stock split effective on 12 Sept 2022

Shares were split 9 : 8 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Jun 2022

EPS came in at -kr 0.17 .

Earnings released on 31 Mar 2022

EPS came in at -kr 0.11 .

Earnings released on 31 Dec 2021

EPS came in at -kr 0.19 .

Earnings released on 30 Sept 2021

EPS came in at -kr 0.21 , while revenue for the quarter reached kr 2.71M .

Earnings released on 30 Jun 2021

EPS came in at -kr 0.31 .

Earnings released on 31 Mar 2021

EPS came in at -kr 0.16 .

BIOSGN.ST Stock Performance

Access detailed BIOSGN.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run